Siepe Stefanie, Lueckel Barbara, Kramer Andrea, Ries Angelika, Gurny Robert
Novartis Pharma AG, Technical R&D, Lichtstrasse 35, CH-4056 Basel, Switzerland.
Int J Pharm. 2006 Jun 19;316(1-2):14-20. doi: 10.1016/j.ijpharm.2006.02.021. Epub 2006 Mar 23.
Incorporation of weak acids as pH modifiers enhances the release of weakly basic drugs in higher pH environments by reducing the microenvironmental pH (pHM). The objectives of this study were: (a) to investigate the relationship between pHM, drug release, and pH modifier release and (b) to achieve simultaneous release of the drug and the pH modifier over the entire dissolution time (6 h, phosphate buffer, pH 6.8). Using dipyridamole as a model drug, we investigated drug and acid release and determined the average pHM potentiometrically using tablet cryosections. The first approach was based on incorporating different concentrations of pH modifiers in conventional matrix tablets based on hydroxypropylmethylcellulose. Owing to its high acidic strength and low aqueous solubility, fumaric acid resulted in simultaneous release and maintained a constant acidic pHM. Secondly, press-coated matrix tablets, comprising an acidic reservoir, were found to be a valuable approach for retarding the diffusion of more water-soluble acids. Using the power law expression (Mt/Minfinity = ktn) it became evident that the inclusion of acids increased drug release. Higher acid concentrations tended to decrease n standing for the slope, whereas the release constant k increased. Furthermore, the medial check term parameters depended on the type of pH modifier used.
加入弱酸作为pH调节剂可通过降低微环境pH值(pHM)来增强弱碱性药物在较高pH环境中的释放。本研究的目的是:(a)研究pHM、药物释放和pH调节剂释放之间的关系,以及(b)在整个溶解时间(6小时,pH 6.8的磷酸盐缓冲液)内实现药物和pH调节剂的同步释放。以双嘧达莫为模型药物,我们研究了药物和酸的释放情况,并使用片剂冷冻切片通过电位滴定法测定了平均pHM。第一种方法是在基于羟丙基甲基纤维素的传统基质片剂中加入不同浓度的pH调节剂。由于富马酸具有高酸性强度和低水溶性,它实现了同步释放并维持了恒定的酸性pHM。其次,包含酸性储库的压制包衣基质片剂被发现是一种延缓水溶性更高的酸扩散的有效方法。使用幂律表达式(Mt/Minfinity = ktn)可以明显看出,加入酸会增加药物释放。较高的酸浓度往往会降低代表斜率的n值,而释放常数k会增加。此外,中间检查项参数取决于所用pH调节剂的类型。